Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

{{article.zuoZheEn}}

PDF(4983 KB)
PDF(4983 KB)
Front. Med. ›› 2023, Vol. 17 ›› Issue (2) : 290-303. DOI: 10.1007/s11684-022-0956-8
RESEARCH ARTICLE

Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2023, 17(2): 290‒303 https://doi.org/10.1007/s11684-022-0956-8

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
PDF(4983 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉